N,N.N'.N'-tetramethyl-10H-phenothiazine-3.7-diaminium ethanedisulfonate | 1393348-80-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻嗪类
• 英文名称: N,N.N'.N'-tetramethyl-10H-phenothiazine-3.7-diaminium ethanedisulfonate
• 英文别名: N,N,N',N'-Tetramethyl-10H-phenothiazine-3,7-diaminium ethanedisulfonate；[7-(dimethylazaniumyl)-10H-phenothiazin-3-yl]-dimethylazanium;ethane-1,2-disulfonate
• CAS: 1393348-80-5
• 化学式: C₂H₆O₆S₂*C₁₆H₁₉N₃S
• 分子量: 475.611
• InChiKey: QTZMIANURNPOQL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.48
• 重原子数：
  30
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  177
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  亚甲兰 在 hydrazine hydrate 、 三乙胺 作用下， 以 乙醇 、 水 、 乙腈 为溶剂， 反应 6.5h， 生成 N,N.N'.N'-tetramethyl-10H-phenothiazine-3.7-diaminium ethanedisulfonate
  参考文献：
  名称：

  [EN] PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE
  [FR] SELS DE DIAMINIUM DE PHÉNOTHIAZINE ET LEURS APPLICATIONS

  摘要：

  公开号：

  WO2012107706A8

文献信息

• PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE
  申请人：Clunas Scott

  公开号：US20130315992A1

  公开（公告）日：2013-11-28

  The invention relates to compounds of general formula (I): wherein: each of R 1 and R 9 is independently selected from: —H, C 1-4 alkyl, C 2-4 alkenyl, and halogenated C 1-4 alkyl; each of R 3NA and R 3NB is independently selected from: —H, C 1-4 alkyl, C 2-4 alkenyl, and halogenated C 1-4 alkyl; each of R7NA and R7NB is independently selected from: —H, C 1-4 alkyl, C 2-4 alkenyl, and halogenated C 1-4 alkyl; and wherein: each of R A and R B is independently selected from: C 1-4 alkyl, halogenated C 1-4 alkyl, and C 6-10 aryl; or R A and R B are linked to form a group selected from: C 1-6 alkylene and C 6-10 arylene; and pharmaceutically acceptable salts thereof, which are useful in the treatment of, for example, Alzheimer's disease. In other aspects the invention also relates to novel formulations of 3,7-diamino-10H-phenothiazinium salts.

  该发明涉及通式（I）的化合物：其中：R1和R9各自独立地选自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；R3NA和R3NB各自独立地选自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；R7NA和R7NB各自独立地选自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；其中：RA和RB各自独立地选自：C1-4烷基，卤代C1-4烷基和C6-10芳基；或RA和RB连接形成所选的基团，所选的基团选自：C1-6烷基和C6-10芳基；以及其药学上可接受的盐，其在例如阿尔茨海默病的治疗中有用。在其他方面，该发明还涉及3,7-二氨基-10H-苯并噻吩盐的新配方。
• Phenothiazine diaminium salts and their use
  申请人：Clunas Scott

  公开号：US09283230B2

  公开（公告）日：2016-03-15

  The invention relates to compounds of general formula (I): wherein: each of R1 and R9 is independently selected from: —H, C1-4alkyl, C2-4alkenyl, and halogenated C1-4alkyl; each of R3NA and R3NB is independently selected from: —H, C1-4alkyl, C2-4alkenyl, and halogenated C1-4alkyl; each of R7NA and R7NB is independently selected from: —H, C1-4alkyl, C2-4alkenyl, and halogenated C1-4alkyl; and wherein: each of RA and RB is independently selected from: C1-4alkyl, halogenated C1-4alkyl, and C6-10aryl; or RA and RB are linked to form a group selected from: C1-6 alkylene and C6-10 arylene; and pharmaceutically acceptable salts thereof, which are useful in the treatment of, for example, Alzheimer's disease. In other aspects the invention also relates to novel formulations of 3,7-diamino-10H-phenothiazinium salts.

  本发明涉及一般式（I）的化合物：其中：R1和R9分别独立选择自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；R3NA和R3NB各自独立选择自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；R7NA和R7NB各自独立选择自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；其中：RA和RB各自独立选择自：C1-4烷基，卤代C1-4烷基和C6-10芳基；或者RA和RB连接形成选择自：C1-6烷基和C6-10芳基的基团；以及其药学上可接受的盐，用于治疗例如阿尔茨海默病等疾病。在其他方面，本发明还涉及3,7-二氨基-10H-苯并噻吩盐的新型配方。
• [EN] PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE<br/>[FR] SELS DE DIAMINIUM DE PHÉNOTHIAZINE ET LEURS APPLICATIONS
  申请人：WISTA LAB LTD

  公开号：WO2012107706A8

  公开（公告）日：2013-09-19